Corrigendum to "Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells" [FEBS Lett. 581 (2007) 1417-1424] (DOI:10.1016/j.febslet.2007.02.064);Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells

FEBS Letters

Volumn 581, Issue 7, 2007, Pages 1417-1424

  Morita, Yoshikata ^a   Araki, Hisazumi ^a   Sugimoto, Toshiro ^a   Takeuchi, Keisuke ^a   Yamane, Takuya ^a   Maeda, Toshinaga ^a   Yamamoto, Yoshio ^a   Nishi, Katsuji ^a   Asano, Masahide ^d   Shirahama Noda, Kanae ^d   Nishimura, Mikio ^d   Uzu, Takashi ^a   Hara Nishimura, Ikuko ^c   Koya, Daisuke ^b   Kashiwagi, Atsunori ^a   Ohkubo, Iwao ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

Extracellular matrix remodeling; Fibronectin; Legumain; Lysosomal peptidase; Renal proximal tubular cell; Unilateral ureteral obstruction

Indexed keywords

CHLOROQUINE; CYSTEINE PROTEINASE; FIBRONECTIN; LEGUMAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEGRADATION KINETICS; ENDOSOME; ENZYME REGULATION; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE OVEREXPRESSION; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; LYSOSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URETER OBSTRUCTION;

MUS;

EID: 33947395690     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.06.054     Document Type: Erratum

References (41)

1. Ishii S. Legumain: asparaginyl endopeptidase. Methods Enzymol. 244 (1994) 604-615
2. Chen J.M., Rawlings N.D., Stevens R.A., and Barrett A.J. Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett. 441 (1998) 361-365
3. Hara-Nishimura I., Takeuchi Y., and Nishimura M. Molecular characterization of a vacuolar processing enzyme related to a putative cysteine proteinase of Schistosoma mansoni. Plant Cell 5 (1993) 1651-1659
4. Shimada T., et al. Vacuolar processing enzymes are essential for proper processing of seed storage proteins in Arabidopsis thaliana. J. Biol. Chem. 278 (2003) 32292-32299
5. Hatsugai N., Kuroyanagi M., Yamada K., Meshi T., Tsuda S., Kondo M., Nishimura M., and Hara-Nishimura I. A plant vacuolar protease, VPE, mediates virus-induced hypersensitive cell death. Science 305 (2004) 855-858
6. Chen J.M., et al. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272 (1997) 8090-8098
7. Shirahama-Noda K., Yamamoto A., Sugihara K., Hashimoto N., Asano M., Nishimura M., and Hara-Nishimura I. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J. Biol. Chem. 278 (2003) 33194-33199
8. Chen J.M., Dando P.M., Stevens R.A., Fortunato M., and Barrett A.J. Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem. J. 335 Pt 1 (1998) 111-117
9. Yamane T., Takeuchi K., Yamamoto Y., Li Y.H., Fujiwara M., Nishi K., Takahashi S., and Ohkubo I. Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein. Biochim. Biophys. Acta 1596 (2002) 108-120
10. Oosterling S.J., et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J. Pathol. 207 (2005) 147-155
11. Liu C., Sun C., Huang H., Janda K., and Edgington T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63 (2003) 2957-2964
12. Murthy R.V., Arbman G., Gao J., Roodman G.D., and Sun X.F. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin. Cancer Res. 11 (2005) 2293-2299
13. Moparthi S.B., Arbman G., Wallin A., Kayed H., Kleeff J., Zentgraf H., and Sun X.F. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int. J. Oncol. 30 (2007) 91-95
14. Luo Y., et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J. Clin. Invest. 116 (2006) 2132-2141
15. Papaspyridonos M., et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1837-1844
16. Inoue S., and Leblond C.P. Three-dimensional network of cords: the main component of basement membranes. Am. J. Anat. 181 (1988) 341-358
17. Chevalier R.L. Specific molecular targeting of renal injury in obstructive nephropathy. Kidney Int. 70 (2006) 1200-1201
18. Koya D., et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. Faseb J. 14 (2000) 439-447
19. Sottile J., and Hocking D.C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell 13 (2002) 3546-3559
20. Evans T., Deng D.X., Chen S., and Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 49 (2000) 662-666
21. Yokoi H., et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am. J. Physiol. Renal Physiol. 282 (2002) F933-F942
22. Klahr S. Urinary tract obstruction. Semin. Nephrol. 21 (2001) 133-145
23. Morrissey J.J., and Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am. J. Physiol. 274 (1998) F580-F586
24. Guo G., Morrissey J., McCracken R., Tolley T., Liapis H., and Klahr S. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am. J. Physiol. Renal Physiol. 280 (2001) F777-F785
25. Kaneto H., Morrissey J., McCracken R., Reyes A., and Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int. 45 (1994) 1637-1647
26. Ishiguro H., Ohkubo I., Mizokami M., Titani K., and Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 8 (1989) 303-313
27. Sekiguchi K., Siri A., Zardi L., and Hakomori S. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. J. Biol. Chem. 260 (1985) 5105-5114
28. Fu P., et al. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J. Am. Soc. Nephrol. 17 (2006) 3105-3114
29. Takaya K., Koya D., Isono M., Sugimoto T., Sugaya T., Kashiwagi A., and Haneda M. Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am. J. Physiol. Renal. Physiol. 284 (2003) F1037-F1045
30. Okada H., et al. A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am. J. Pathol. 169 (2006) 1577-1589
31. Ostendorf T., et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 17 (2006) 1054-1062
32. Alvarez-Fernandez M., Barrett A.J., Gerhartz B., Dando P.M., Ni J., and Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274 (1999) 19195-19203
33. Kornblihtt A.R., Umezawa K., Vibe-Pedersen K., and Baralle F.E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. Embo J. 4 (1985) 1755-1759
34. East L., McCarthy A., Wienke D., Sturge J., Ashworth A., and Isacke C.M. A targeted deletion in the endocytic receptor gene Endo180 results in a defect in collagen uptake. EMBO Rep. 4 (2003) 710-716
35. Sottile J., and Chandler J. Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol. Biol. Cell 16 (2005) 757-768
36. Eddy A.A. Molecular basis of renal fibrosis. Pediatr. Nephrol. 15 (2000) 290-301
37. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69 (2006) 213-217
38. Adhikary L.P., Yamamoto T., Isome M., Nakano Y., Kawasaki K., Yaoita E., and Kihara I. Expression profile of extracellular matrix and its regulatory proteins during the process of interstitial fibrosis after anti-glomerular basement membrane antibody-induced glomerular sclerosis in Sprague-Dawley rats. Pathol. Int. 49 (1999) 716-725
39. Norman J.T., and Fine L.G. Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp. Nephrol. 7 (1999) 167-177
40. Jernigan S., and Eddy A.A. Experimental insights into the mechanisms of tubulo-interstitial scarring. In: El Nahas A., Harris K., and Anderson S. (Eds). Mechanisms and Clinical Management of Chronic Renal Failure (2000), Oxford University Press, Oxford 104-145
41. Chen J.M., Fortunato M., Stevens R.A., and Barrett A.J. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol. Chem. 382 (2001) 777-783